Literature DB >> 12894160

Skipping to new gene therapies for muscular dystrophy.

James G Tidball, Melissa J Spencer.   

Abstract

Entities:  

Keywords:  Non-programmatic

Mesh：

Substances：

Year:  2003        PMID： 12894160     DOI： 10.1038/nm0803-997

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy.

Authors:  Hiroshi Akima; Donovan Lott; Claudia Senesac; Jasjit Deol; Sean Germain; Ishu Arpan; Roxanna Bendixen; H Lee Sweeney; Glenn Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2011-07-31       Impact factor: 4.296

2.  Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.

Authors:  Yin Tang; Yang-Bing Li; Bo Wang; Ri-Yuan Lin; Mallory van Dongen; Danielle M Zurcher; Xiao-Yan Gu; Mark M Banaszak Holl; George Liu; Rong Qi
Journal:  Mol Pharm       Date:  2012-05-14       Impact factor: 4.939

3.  Polymersome delivery of siRNA and antisense oligonucleotides.

Authors:  Younghoon Kim; Manorama Tewari; J David Pajerowski; Shenshen Cai; Shamik Sen; Jason H Williams; Jason Williams; Shashank R Sirsi; Shashank Sirsi; Gordon J Lutz; Gordon Lutz; Dennis E Discher
Journal:  J Control Release       Date:  2008-11-12       Impact factor: 9.776

4.  Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study.

Authors:  Skorn Ponrartana; Leigh Ramos-Platt; Tishya Anne Leong Wren; Houchun Harry Hu; Thomas Gardner Perkins; Jonathan Mawlin Chia; Vicente Gilsanz
Journal:  Pediatr Radiol       Date:  2014-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.